Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  amphotericin B deoxycholate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-24 of 24 for your search:
Start Over
Phase III Randomized Study of Liposomal Nystatin vs Standard Amphotericin B for Empiric Treatment of Persistent Febrile Neutropenic Patients (Summary Last Modified 05/2000)
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 2 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AR-95-41.356-006, NCI-V96-0845, NCT00002742
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 12 and over
Sponsor: Other
Protocol IDs: EORTC-19961, PFIZER-150-307-000, NCT00003031
Phase III Study of Chemotherapy with ADR/CCNU/HMM/MTX and Amphotericin B for Advanced non-Small Cell Bronchogenic Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CHNMC-COH-CA-LUN-1, NCI-D80-035-131
Phase III Empirical Antimicrobial Therapy vs Early Open Lung Biopsy/Specific Therapy for Diffuse Interstitial Pneumonitis in Immunocompromised Patients
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: NCI-82-C-111
Phase III Management and Prophylaxis of Fever and Infection with Antimicrobial Treatment in Cancer Patients (Study III)
Phase: Phase III
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-81-C-189, NCI-POB-8103
Phase III Maintenance Chemotherapy vs TBI/Marrow Transplant Following Conventional Induction and Consolidation for ANLL
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8124/25/26, SWOG-8124, SWOG-8125, SWOG-8126
Phase III Amphotericin-B vs Amphotericin-B/Rifampin for Cancer Patients with Suspected Fungal Infections
Phase: Phase III
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-7601
Phase III MOX/AMK vs MOX/PIP for Suspected Infection in Febrile, Granulocytopenic Cancer Patients, with Amphotericin-B or Ketoconazole for Failures
Phase: Phase III
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-8107
Phase II Chemotherapy with Amphotericin B plus FAC: 5-FU/ADR/CTX for Advanced Metastatic Breast Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-MBDT-7734
Phase II Management of Fever and Infection in Cancer Patients --- Fever Study IV (Summary Last Modified 06/97)
Phase: Phase II
Type: Supportive care
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: NCI-85-C-212C, NCI-T86-0036N, T86-0036
Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 3 to 18
Sponsor: Other
Protocol IDs: FSJD-ABELNEB-2010, NCT01615809
Chemotherapy with Cyvadic plus Amphotericin B for Metastatic Sarcoma
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDAR-249
Protected Environment and Prophylactic Antibiotic (PEPA) Program with Chemotherapy and Immunotherapy for Acute Leukemia
Phase: No phase specified
Type: Supportive care, Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7309
Chemotherapy with ADR/CTX/MTX vs ADR/CTX/MTX/Amphotericin-B & Maintenance with ACT-D vs ACT-D/Amphotericin-B for Metastatic Sarcoma
Phase: No phase specified
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: SEG-78SAR327, SEG-78SAR0103
Comparison of Oral Antibiotic Combinations to Prevent Infections in Relapsed Leukemic Patients and in Oat Cell Carcinoma Patients
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-7714
Empiric Antibiotic Therapy for Febrile Granulocytopenic Cancer with Suspected Infection
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-8014
Comparison of Azlocillin/Amikacin vs Cefotaxime/Amikacin vs Ticarcillin/Amikacin in the Empirical Treatment of the Febrile, Granulocytopenic Cancer Patient
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: EORTC-46801
Randomized Comparison of Two Regimens of Selective Microbial Decontamination in Acute Leukemia Patients Undergoing Induction Chemotherapy
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 14 to 60
Sponsor:
Protocol IDs: EORTC-38811
Randomized Prospective Trial of Ceftazidime with and without Vancomycin in the Management of Febrile Granulocytopenic Patients (Summary Last Modified 11/87)
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-86-C-227, NCI-NMOB-863, NCI-T87-0022N, T87-0022
Randomized Study of Intranasal Amphotericin B as Prophylaxis for Aspergillus Infection in Neutropenic Patients (Summary Last Modified 08/92)
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 16 and over
Sponsor:
Protocol IDs: SCCC-91090, NCI-V92-0085
Start Over